Celyad Oncology S.A. CYAD
0.47 0.00 (+0.00%)
At closeMay 18, 2023, 4:00 PM EDT
0.47 Day range 0.528
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 8.52
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 3.31K | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 9.88M | +298833.5% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 11, 2022 | Wells Fargo | Maintained | — | Overweight |
| Aug 6, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 26, 2021 | JonesTrading | Downgrade | Buy | Hold |
| Dec 8, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 26, 2020 | Wells Fargo | Maintained | — | Overweight |
| Mar 25, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Jul 2, 2018 | H.C. Wainwright | Initiated | — | Buy |
| May 31, 2018 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| May 25, 2018 | Wells Fargo | Initiated | — | Outperform |
| Jul 5, 2016 | UBS | Downgrade | Buy | Neutral |
| Aug 26, 2015 | UBS | Maintained | — | Buy |
| Jul 14, 2015 | UBS | Initiated | — | Buy |